The following is a list of the most commonly prescribed drugs. It represents an abbreviatedversion of the drug list (formulary) that is at the core of your prescription-drug benefit plan. The list is not all-inclusive and does not guarantee coverage. In addition to using this list,you are encouraged to ask your doctor to prescribe generic drugs whenever appropriate. PLEASE NOTE: The symbol * next to a drug signifies that it is subject to nonformulary status 2013 Express Scripts when a generic is available throughout the year. Not all the drugs listed are covered by all prescription-drug benefit programs; check your benefit materials for the specific drugs National Preferred Formulary covered and the copayments for your prescription-drug benefit program. For specific questions about your coverage, please call the phone number printed on your ID card. A B D G O H E C M I P J F K N L THIS DOCUMENT LIST IS EFFECTIVE JANUARY 1, 2013 THROUGH DECEMBER 31, 2013. THIS LIST IS SUBJECT TO CHANGE. You can get more information and updates to this document at our website at www.express-scripts.com. 2013 Express Scripts Holding Company #3507 NP-A W SSM All Rights Reserved PRMT22157SSM-13 (08/13/12) Examples of Nonformulary Medications With Selected Formulary Alternatives
The following is a list of some nonformulary brand-name medications with examples of selected alternatives that are on the formulary.
Column 1 lists examples of nonformulary medications.
Column 2 lists some alternatives that can be prescribed. Nonformulary Formulary Alternative Nonformulary Formulary Alternative
fenofibrate/micronized, Tricor*, Trilipix
fenofibrate/micronized, Tricor*, Trilipix
Q
ciprofloxacin/er, levofloxacin, ofloxacin,
U R V
ORTHO EVRA, ORTHO generic oral contraceptives, Beyaz,
ciprofloxacin/er, levofloxacin, ofloxacin,
S
oxybutynin er, Detrol LA, Enablex, Toviaz,
ciprofloxacin/er, levofloxacin, ofloxacin,
W X
fenofibrate/micronized, Tricor*, Trilipix
fenofibrate/micronized, Tricor*, Trilipix
FLOVENT DISKUS, HFA Asmanex, Pulmicort Flexhaler, Qvar
Z
fenofibrate/micronized, Tricor*, Trilipix
T KEY The symbol [INJ] next to a drug name indicates that the drug is available in injectable form only.
The symbol [ST] next to a drug name indicates that Step Therapy may apply to some or all strengths of the drug. For the member: Generic medications contain the same active ingredients as their corresponding brand-name medications, although
they may look different in color or shape. They have been FDA-approved under strict standards. For the physician: Please prescribe preferred products and allow generic substitutions when medically appropriate. Thank you.
Brand-name drugs are listed in CAPITAL letters.
Generic drugs are listed in lower case letters. THIS DOCUMENT LIST IS EFFECTIVE JANUARY 1, 2013 THROUGH DECEMBER 31, 2013. THIS LIST IS SUBJECT TO CHANGE. You can get more information and updates to this document at our website at www.express-scripts.com. 2013 Express Scripts Holding Company #3507 NP-A W SSM All Rights Reserved PRMT22157SSM-13 (08/13/12)
A.8. PARTITION COEFFICIENT The 'shake flask' method described is based on the OECD Test Guideline (1). 1.1. INTRODUCTION It is useful to have preliminary information on structural formula, dissociation constant, water solubility, hydrolysis, n-octanol solubility and surface tension of the substance to perform this test. Measurements should be made on ionizable substances only in their non -i
March 2002 Specific-IgE tests may indicate asthma risk SYNOPSIS and the possibility of prevention 795 infants (aged 1–2 years) with atopic dermatitis (AD) receivedplacebo or cetirizine for 18 months. This report from the ETAC study group shows that specific-IgE screeningof infants with AD indicates those who are at risk of developing asthma. 566 of these children were followed fo